Several Non-steroidal anti-inflammatory drugs (NSAIDs) that can inhibit the expression of NF-κB have been attempted in AD therapy, however, no beneficial results in AD patients were observed [43]. This evidence concerns the gene NFKB1 and Alzheimer disease.